New Zealand markets close in 5 hours 34 minutes

Profound Medical Corp. (PROF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.84+0.03 (+0.38%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,199
7,199
6,681
6,873
7,304
Cost of revenue
2,817
2,817
3,660
3,921
3,830
Gross profit
4,382
4,382
3,021
2,952
3,474
Operating expenses
Research development
14,377
14,377
14,690
15,277
9,912
Selling general and administrative
18,621
18,621
17,933
17,966
12,425
Total operating expenses
32,998
32,998
32,623
33,243
22,337
Operating income or loss
-28,616
-28,616
-29,602
-30,291
-18,863
Interest expense
770
770
174
67
543
Total other income/expenses net
-807
-807
301
7
-2,863
Income before tax
-28,697
-28,697
-28,382
-30,594
-21,577
Income tax expense
-128
-128
287
105
45
Income from continuing operations
-28,569
-28,569
-28,669
-30,699
-21,622
Net income
-28,569
-28,569
-28,669
-30,699
-21,622
Net income available to common shareholders
-28,569
-28,569
-28,669
-30,699
-21,622
Basic EPS
-1.39
-
-1.38
-1.50
-1.25
Diluted EPS
-1.39
-
-1.38
-1.50
-1.25
Basic average shares
21,080
-
20,830
20,466
17,295
Diluted average shares
21,080
-
20,830
20,466
17,295